Justin Meiklem

Grant to partially fund research that will enable faster development, with a higher probability of success, of new plant-based compounds (precision botanics) for the benefit of BioHarvest’s CDMO customers and partners Vancouver, British Columbia and Rehovot, Israel- – BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today

Vancouver, British Columbia and Rehovot, Israel – July 13, 2026 – BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that its Chief Executive Officer, Zaki Rakib, will participate in a fireside chat at the upcoming Maxim Health, Wellness & Longevity Conference, to be held

Vancouver, British Columbia and Rehovot, Israel – June 18, 2026 – BioHarvest Sciences Inc (NASDAQ: BHST) (FSE: 8MV0), a leader in Botanical Synthesis technology and sustainable plant-based molecule development, today announced that it will present at the upcoming BIO International Convention, to be held on June 22-25, in San Diego, California. Presentation Details: BioHarvest Sciences’ presentation will showcase

Expanded sweetener molecule development program aims to broaden access to plant‑based sweetening solutions tailored to diverse customer food and beverage categories. Vancouver, British Columbia and Rehovot, Israel – May 18th, 2026 – BioHarvest Sciences Inc. (Nasdaq: BHST) (FSE: 8MV0), a leader in Botanical Synthesis™ technology and sustainable plant-based molecule development, today announced the expansion of

– CDMO program advances to Stage 2 of development agreement valued at $1.125 million -Advancement of sustainable solution for the production of saffron, one of the world’s most valuable and health-promoting botanicals – In addition to future commercial manufacturing royalties, BioHarvest also holds a 25% ownership position in Saffron Composition   Vancouver, British Columbia and